# Jiangsu T-mab BioPharma (China)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/jiangsu-t-mab-biopharma-china/

## Facts

| Field | Value |
| --- | --- |
| Citations | 7,159 |
| City | Taizhou |
| Country | CN |
| Description | Jiangsu T-mab BioPharma (China) is a research organisation in Taizhou, CN. OpenAlex records 276 works and 7,159 citations for it. 239 researchers list it as their most recent affiliation. |
| Homepage | http://taikang.d79.163ns.cn/ |
| OpenAlex ID | https://openalex.org/I4210109974 |
| Researchers | 239 |
| ROR ID | https://ror.org/017dx9162 |
| Type | company |
| Works | 276 |

## University top topics

Showing 8 of 25.

- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.